Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Pulvinar Neuro | 2023 | Grant | $3.1M | Durham |
| Aqualung Therapeutics | 2023 | Seed | Undisclosed | Tucson |
| Oncospherix | 2023 | Grant | $2.0M | Atlanta |
| Jigsawdio | 2023 | Grant | $500K | Raleigh |
| Biomotum | 2023 | Seed | Undisclosed | Portland |
| Joyuus | 2023 | Grant | $1.7M | West Greenwich |
| Medcognetics | 2023 | Grant | $750K | Dallas |
| Chemeleon | 2023 | Grant | $1.7M | Brooklyn |
| Millennial Scientific | 2022 | Grant | $1.5M | Stony Brook |
| Efemoral Medical | 2022 | Series A | $4.9M | Los Altos |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 201 | Pulvinar Neuro | Grant | $3.1M | Durham, United States |
| 202 | Aqualung Therapeutics | Seed | Undisclosed | Tucson, United States |
| 203 | Oncospherix | Grant | $2.0M | Atlanta, United States |
| 204 | Jigsawdio | Grant | $500K | Raleigh, United States |
| 205 | Biomotum | Seed | Undisclosed | Portland, United States |
| 206 | Joyuus | Grant | $1.7M | West Greenwich, United States |
| 207 | Medcognetics | Grant | $750K | Dallas, United States |
| 208 | Chemeleon | Grant | $1.7M | Brooklyn, United States |
| 209 | Millennial Scientific | Grant | $1.5M | Stony Brook, United States |
| 210 | Efemoral Medical | Series A | $4.9M | Los Altos, United States |
Pulvinar Neuro is to enable and support outstanding basic and translational neuroscience research.
Aqualung Therapeutics is developing a novel, anti-inflammatory monoclonal antibody strategy to treat serious unchecked inflammation.
Oncospherix is the culmination of a multi-year research program for cancer.
Jigsawdio is a women owned platform designed to help people with memory loss.
Wearable rehabilitation robotics
Joyuus is a women's health startup dedicated on creating easily accessible well-being for mothers.
Medcognetics is an IT company that provides cloud-based software-as-a-service leveraging artificial intelligence for the medical sector.
Platform tech for ultra-rapid, instrument-free, point-of-care assays that provide lab-grade precision under one minute anywhere
Advanced material, and manufacturing company focused on Chromatography and allied products
Efemoral Medical is a medical technology company developing treatment solutions for patients suffering from peripheral vascular disease.
Stemloop—The Biosensor Company™—discovers, develops, and deploys cell-free biosensors to address unmet chemical sensing and detection needs.
Soterix Medical develops devices and accessories based on neuromodulation and brain stimulation technologies.
Mi-Helper helps to develop a non-drug remedy for migraine and mood issues.
Reliant Glycosciences is a biotechnology company focused on developing diagnostic and prognostic tools for patients with IgA nephropathy.
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Melax Technologies specializes in machine learning, software, domain, natural language processing and medical coding services.
Pantherics is a new type of therapy based on modulation of peripheral GABAA receptors.
SEngine Precision Medicine uses algorithms and 3D organoid technology to develop drugs with more efficacy.
Atom Bioworks is a developer of a pattern-recognition enabled sensing and therapeutics platform designed to help in medical.
RocketML is a Super Fast Computational engine for Machine Learning.
GenNext Technologies is a platform that provides instrumentation, software, and services to structural biology researchers.
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
Max-IR Labs develops infrared chemical and thermal sensor technology for defence-related products.
Immunicom is a biotechnology company.
Support and development of SciDAP - next generation user-friendly universal data analysis platform for biologists and bioinformaticians
National Institutes of Health has invested in 288 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institutes of Health's top investment sectors include Health Care, Biotechnology, Medical, Medical Device, Software. The firm invests across 31 different industry categories.
Among tracked funding rounds, SEngine Precision Medicine received $10.0M in a Series A round. National Institutes of Health's total known invested capital is $1.3B.
National Institutes of Health's average investment size is $6.6M across its portfolio of 288 companies.
Recent National Institutes of Health portfolio additions include Pulvinar Neuro, Aqualung Therapeutics, Oncospherix, Jigsawdio, Biomotum. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors